Incyte (INCY) Change in Acquisitions & Divestments (2010 - 2025)
Incyte (INCY) posted Change in Acquisitions & Divestments of -$209.6 million for Q4 2025, down 294.4% on a QoQ basis from $107.8 million in Q3 2025, and down 306.29% year-over-year from $101.6 million in Q4 2024.
Incyte (INCY) Change in Acquisitions & Divestments (2010 - 2025) Analysis & Trends
Incyte's Change in Acquisitions & Divestments history runs 16 years deep, the most recent figure standing at -$209.6 million for Q4 2025.
- Quarterly Change in Acquisitions & Divestments fell 306.29% year-over-year to -$209.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8000.0 (down 100.0% YoY) and the FY2025 annual result came in at $8000.0, down 100.0% from the prior year.
- Change in Acquisitions & Divestments was -$209.6 million for Q4 2025 at Incyte, down from $107.8 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $305.7 million in Q4 2023 and bottomed at -$209.6 million in Q4 2025.
- A 5-year average of $45.2 million and a median of $1.1 million in 2021 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments soared 58410.85% — and 2025, when it slumped 306.29%.
- Incyte's Change in Acquisitions & Divestments stood at $221.0 million in 2021, then plunged by 100.12% to -$258000.0 in 2022, then jumped by 118603.49% to $305.7 million in 2023, then sank by 116.88% to -$51.6 million in 2024, then plunged by 306.29% to -$209.6 million in 2025.
- Business Quant data shows INCY's Change in Acquisitions & Divestments at -$209.6 million in Q4 2025, $107.8 million in Q3 2025, and $101.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Incyte | 23.64 Bn | 19.62 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -209.64 Mn |
| Dec 31, 2025 | -209.64 Mn |
| Sep 30, 2025 | 107.84 Mn |
| Sep 30, 2025 | 107.84 Mn |
| Jun 30, 2025 | 101.80 Mn |
| Jun 30, 2025 | 101.80 Mn |
| Mar 31, 2025 | 8,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | -51.60 Mn |
| Dec 31, 2024 | -51.60 Mn |
| Sep 30, 2024 | 55.61 Mn |
| Sep 30, 2024 | 55.61 Mn |
| Jun 30, 2024 | 227.26 Mn |
| Jun 30, 2024 | 227.26 Mn |
| Dec 31, 2023 | 305.74 Mn |
| Dec 31, 2023 | 305.74 Mn |
| Sep 30, 2023 | -150.44 Mn |
| Sep 30, 2023 | -150.44 Mn |
| Jun 30, 2023 | 150.44 Mn |
| Jun 30, 2023 | 150.44 Mn |